Sexual harassment complaints: 2 FIRs registered against Wrestling Federation of India chief, 1 of them under Pocso
Coronavirus situation under control in Delhi, not terrible, says Kejriwal
Maruti reports 54% YoY decline in sales in June; sells less than 40% of pre-coronavirus level
Government Bans 59 Chinese Apps Including Tik-Tok, Shareit, UC Browser, and WeChat
PM Modi to address the nation at 4 pm: What to expect
Maharashtra Extends Lockdown Till July 31 Day After Urging Caution
Coronavirus Vaccine Update
Swarms Of Desert Locusts Reach Delhi Outskirts After Gurugram
Delhi fighting difficult battle against COVID-19, will emerge victorious: Kejriwal
2-Week Lockdown In Guwahati From Monday; Minister Says "Shop By Sunday"
YouTube likely to come up with TikTok-like short video platform
Rs 2,000 crore from PM CARES Fund to be spent on 50,0000 ventilators for COVID-19 patients
Baba Ramdev's Patanjali launches India's 'first Ayurvedic' medicine for coronavirus, Coronil
Coronavirus: Glenmark conducts Fabiflu trial on 1,000 patients; to compete with Gilead's Remdesivir
Jio's golden touch makes Reliance Industries share rise 108% in 3 months
Coronavirus vaccine: When will it be ready? Moderna, AstraZeneca offer answers
Chennai lockdown starts today: Check what is allowed, not allowed
Coronavirus vaccine: Singapore scientists discover 5 antibodies that can combat COVID-19
India-China tension: Indian Army releases list of 20 martyrs; wreath ceremony begins in Leh
Tamil Nadu announces 'maximised restricted lockdown' from June 19 in Chennai, 3 other districts

Latest Posts

Coronavirus: Animal healthcare manufacturer joins hands with IIT to develop vaccine

latest news update

Ahmedabad-based Hester Biosciences, a leading animal healthcare and second largest poultry vaccine manufacturer in India, has joined hands with the Indian Institute of Technology (IIT), Guwahati to develop a vaccine for Covid-19.  Hester becomes the 8th Indian company to attempt a Covid-19 vaccine  after Serum Institute, Zydus Cadila, Bharat Biotech, Indian Immunologicals, Biological E, CCMB Hyderabad and IISc Bangalore with Mynvax, Bangalore.

The vaccine will be based on recombinant avian paramyxovirus based vector platform, which has been used in the past as a vaccine vector for various animals and human pathogens such as HIV, avian influenza virus, human parainfluenza virus, SARS-CoV and many other infectious diseases like Nipah. The partners are hoping to have a vaccine candidate ready for animal trials by end of the year and enter human trials during next year, said Rajiv Gandhi, CEO and MD, Hester Biosciences.

"While our involvement would be from master seed development up to release of the commercial vaccine, the IIT team headed by Dr. Sachin Kumar, Associate Professor, Department of Biosciences and Bioengineering, is to produce the recombinant vaccine candidate. It is early to fix the timelines," said Rajiv Gandhi. This will be the first initiative from Hester to develop a human vaccine.

Being in veterinary vaccine manufacturing, as well as working towards developing recombinant vaccines, Hester has a fairly good understanding and the capability to get into human vaccines, he said.


Alert Message

Please Wait...

Share the Opinion Poll with your Friends At


Share the Survey with your
Friends At